<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Stopping power monitoring during proton therapy by means of prompt gamma timing: first experimental results with a homogeneous phantom - Health AI Hub</title>
    <meta name="description" content="This paper introduces the first experimental results of Spatiotemporal Emission Reconstruction from Prompt-Gamma Timing (SER-PGT), a novel method designed to mo">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Stopping power monitoring during proton therapy by means of prompt gamma timing: first experimental results with a homogeneous phantom</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.21344v1" target="_blank">2511.21344v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-26
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Julius Werner, Francesco Pennazio, Piergiorgio Cerello, Elisa Fiorina, Simona Giordanengo, Felix Mas Milian, Alessio Mereghetti, Franco Mostardi, Marco Pullia, Sahar Ranjbar, Roberto Sacchi, Anna Vignati, Magdalena Rafecas, Veronica Ferrero
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> physics.med-ph
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.21344v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2511.21344v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces the first experimental results of Spatiotemporal Emission Reconstruction from Prompt-Gamma Timing (SER-PGT), a novel method designed to monitor stopping power and particle range during proton therapy. Using a sub-clinical proton beam on a homogeneous phantom, the technique demonstrated accurate stopping power estimation with an 8% average error and successfully identified range shifts, highlighting its potential to reduce treatment uncertainties and enable adaptive planning.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research is crucial for advancing proton therapy by enabling real-time monitoring of proton range and stopping power, which can significantly reduce uncertainties in dose delivery. This capability is essential for optimizing treatment plans, minimizing damage to healthy tissues, and facilitating adaptive treatment strategies to improve patient outcomes.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>None explicitly mentioned in the abstract. The paper describes a physics-based monitoring and reconstruction method without specifying the use of artificial intelligence or machine learning techniques.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Proton therapy's efficacy is currently limited by uncertainties in dose distribution, which SER-PGT aims to mitigate by providing real-time monitoring capabilities.</li>
                    
                    <li>SER-PGT allows for the reconstruction of both particle range and stopping power profiles without requiring prior knowledge of patient tissue properties, addressing a key challenge in proton therapy.</li>
                    
                    <li>The experimental setup utilized a 226.9 MeV synchrotron-proton beam at sub-clinical intensity (2-4 x 10^7 pps) incident on a homogeneous phantom.</li>
                    
                    <li>The system employs a multi-detector array: a thin, segmented Low Gain Avalanche Diode (LGAD) for proton detection and Lanthanum Bromide (LaBr3)-based crystals for prompt gamma photon detection.</li>
                    
                    <li>The estimated stopping power profile achieved an 8% +/- 3% average error when compared to NIST PSTAR values and a 2% +/- 2% deviation relative to water at 100 MeV.</li>
                    
                    <li>Range assessment successfully detected a known 4 cm air-gap induced range shift in the phantom with a standard deviation of 3 mm.</li>
                    
                    <li>These results demonstrate the fundamental feasibility of using SER-PGT to simultaneously recover both range and stopping power information by combining particle kinematics and prompt gamma timing measurements.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The study utilized a 226.9 MeV synchrotron-proton beam directed at a homogeneous phantom. A multi-detector system was employed, consisting of a thin, segmented Low Gain Avalanche Diode (LGAD) for detecting incoming protons and Lanthanum Bromide (LaBr3)-based scintillators for detecting prompt gamma emissions. Prompt gamma timing (PGT) data, combined with particle kinematics, were then processed using the SER-PGT method to reconstruct stopping power profiles and assess particle range.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The SER-PGT method successfully estimated stopping power profiles with an average error of 8% +/- 3% compared to NIST PSTAR values, and a 2% +/- 2% deviation relative to water at 100 MeV. The system accurately identified a 4 cm air-gap induced range shift in the phantom with a 3 mm standard deviation, confirming its ability to recover both range and stopping power information.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This technology has the potential to revolutionize proton therapy by allowing for precise, real-time verification of dose delivery, which is currently a major limitation. It could enable truly adaptive treatment planning, where adjustments can be made during or between fractions based on actual proton range and stopping power, leading to more accurate tumor targeting, reduced side effects, and potentially improved cure rates.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The experiments were conducted using a sub-clinical intensity proton beam (2-4 x 10^7 pps) and on a homogeneous phantom, indicating that further validation is needed under clinical conditions and with more complex, heterogeneous tissue models. As 'first experimental results,' the technology is in an early stage of development.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>Not explicitly mentioned in the abstract, but implied by the stated limitations would be to test SER-PGT at clinical beam intensities and with more clinically relevant heterogeneous phantoms, eventually progressing towards in-vivo studies.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Radiation oncology</span>
                    
                    <span class="tag">Medical physics</span>
                    
                    <span class="tag">Cancer treatment</span>
                    
                    <span class="tag">Dosimetry</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Proton therapy</span>
                    
                    <span class="tag tag-keyword">Stopping power</span>
                    
                    <span class="tag tag-keyword">Prompt gamma timing</span>
                    
                    <span class="tag tag-keyword">SER-PGT</span>
                    
                    <span class="tag tag-keyword">Range monitoring</span>
                    
                    <span class="tag tag-keyword">Adaptive therapy</span>
                    
                    <span class="tag tag-keyword">Dosimetry</span>
                    
                    <span class="tag tag-keyword">Particle therapy</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Proton therapy's full potential is limited by uncertainties that prevent optimal dose distribution. Monitoring techniques can reduce these uncertainties and enable adaptive treatment planning. Spatiotemporal Emission Reconstruction from Prompt-Gamma Timing (SER-PGT) is a promising method that provides insights into both particle range and stopping power, whose calculation would normally require knowledge about patient tissue properties that cannot be directly measured. We present the first experimental results using a 226.9 MeV synchrotron-proton beam impinging on a homogeneous phantom at a sub-clinical intensity (2 - 4 x 10^7 pps). SER-PGT uses data from a multi-detector setup: a thin and segmented Low Gain Avalanche Diode for proton detection and Lanthanum Bromide-based crystals for photon detection. The estimated stopping power profile showed an 8% +- 3% average error compared to NIST PSTAR values, and 2% +- 2% deviation relative to water at 100 MeV. Range assessment in a phantom with a 4 cm air-gap successfully identified the range shift with a 3 mm standard deviation. These results demonstrate the feasibility of using SER-PGT to recover both range and stopping power information through particle kinematics and PGT measurements.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>15 pages, 6 figures</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>